X. Qiu
5 Papers
X. Qiu is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Predicting survival and immune microenvironment in colorectal cancer: a STAT signaling-related signature.
TL;DR: In this article, the authors developed an effective prognostic signature for colorectal cancer (CRC) and evaluated its association with immune microenvironment, using gene expression and clinical profiles of CRC patients to construct a signature.
7
Investigating regulatory patterns of NLRP3 Inflammasome features and association with immune microenvironment in Crohn’s disease
Huihuan Wu,Ruijie Zeng,X. Qiu,Kequan Chen,Zewei Zhuo,Kehang Guo,Yawen Xiang,Qi Yang,Rui Jiang,Felix W. Leung,Qizhou Lian,Weihong Sha,Hao Chen +12 more
TL;DR: The role of the NOD-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome in Crohn's disease remains largely unknown as mentioned in this paper .
Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme
Jinghua Wang,X. Qiu,Jiayu Huang,Zewei Zhuo,Hao Chen,Ruijie Zeng,Huihuan Wu,Kehang Guo,Qi Yang,Huili Ye,Wei Huang,Yujun Luo +11 more
TL;DR: Wang et al. as discussed by the authors constructed a mitophagy-related risk model, which can be utilized for the clinical prognostic prediction in GBM, and patients in TCGA and CGGA were classified into low-risk and high-risk groups.
Adverse clinical outcomes and immunosuppressive microenvironment of RHO-GTPase activation pattern in hepatocellular carcinoma
Qi Yang,Zewei Zhuo,X. Qiu,Ruibang Luo,Kehang Guo,Huihuan Wu,Rui Jiang,Jingwei Li,Qizhou Lian,Pengfei Chen,Weihong Sha,Hao Chen +11 more
TL;DR: New insight is provided into the TME features and clinical use of Rho GTPase gene pattern at the bulk-seq and single-cell level, which may contribute to guiding personalized treatment and improving clinical outcome in HCC.
3
Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme
Jinghua Wang,X. Qiu,Jiayu Huang,Zewei Zhuo,Hao Chen,Ruijie Zeng,Huihuan Wu,Kehang Guo,Qi Yang,Huiling Ye,Wei Huang,Yujun Luo +11 more
TL;DR: Wang et al. as discussed by the authors constructed a mitophagy-related risk model, which can be utilized for the clinical prognostic prediction in GBM. But, the model was not validated in an external cohort.